The takeaway
HCA Healthcare, Inc. shows a moderate seasonal pattern over 10 years of data — strongest in January (+5.5%) and softest in February (−1.7%).
Right now
In July, the stock has risen 60% of years, averaging +7.8%, about +5.6 pts better than the S&P 500.
The full picture
HCA Healthcare, Inc.'s most dependable month has been January, higher in 7 of 10 years; February has been its least reliable, up just 30% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | ||||||||||||
| 2021 | ||||||||||||
| 2020 | ||||||||||||
| 2019 | ||||||||||||
| 2018 | ||||||||||||
| 2017 | ||||||||||||
| 2016 |
Month by month
The stock's clearest edge over the S&P 500 lands in January (+5.7 pts); it has trailed the market most in September (−1.5 pts).
“vs S&P” is HCA Healthcare, Inc.’s average for a month minus the S&P 500’s average for that same month — isolating HCA Healthcare, Inc.’s own seasonal edge from broad market drift.
Reality check
Over the last 5 years, January has closed higher 60% of the time versus 70% across the last 10 years — the pattern is holding.
Figures are the typical (median) January return and how often it rose — the last 5 years versus the last 10(the heatmap’s default window). This verdict stays anchored to that 10-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
This is a stock you can almost set a calendar by, and January is the anchor — it has closed higher in 7 of 10 Januaries, the steadiest beat on its year.
The strength looks broad-based rather than freakish: its average (+5.5%) and median (+6.4%) sit close together, so no single blow-out year is flattering the figure. Better still, that strength is the stock's own and not just a buoyant market — January has outpaced the S&P 500 by +5.7 points on average. Few peers keep such company in January — the typical stock clears it just 53% of the time.
January anchors a run, too: the November-through-January window has been the stock's reliable season. The weaker half of the year is plainer: February has been the soft spot — the weakest of 3 months that average a loss (−1.7%), and the edge isn't year-round — the stock has trailed the S&P 500 in September, June, and February. Its roughest month on record was a −33.5% March in 2020 — a reminder of how hard even a seasonal name can fall.
Reassuringly, the tendency has held its shape: the recent five years still track the years behind them.
For a stock this dependable in January, the sharper question is the rest of the year — outside its strong stretch, the calendar gives far less to lean on.
Short answers on the stock's best month (January), its worst (February), and whether it really trades seasonally.
Yes, to a moderate degree. Since 2016 its best month (January, +5.5%) has run well ahead of its worst (February, −1.7%) — the heatmap above shows how steady that gap has been year to year.
January has been the strongest, averaging +5.5% and closing higher in 7 of 10 years since 2016.
It's the weakest, averaging −1.7% — historically a soft spot, though it still varies from year to year.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade